U.S. Physical Therapy (USPH) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
U.S. Physical Therapy (USPH) has outperformed GeneDx (WGS) over the past year, losing 7.6% versus a loss of 43.3%. Over five years, USPH leads with a -20.6% price change compared with -73.3% for WGS. GeneDx is the larger company by market cap ($2.04 billion vs $1.24 billion), about 1.7 times the size.
On valuation, U.S. Physical Therapy trades at a lower forward P/E (24.8x vs 57.2x for GeneDx). U.S. Physical Therapy pays a dividend yielding 2.19%, while GeneDx does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | USPH | WGS |
|---|---|---|
| Share price | $82.96 | $68.53 |
| Market cap | $1.24B | $2.04B |
| 1-day change | -0.80% | -4.18% |
| YTD return | +6.24% | -47.31% |
| 1-year return | -7.59% | -43.25% |
| 5-year return | -20.64% | -73.34% |
| P/E ratio (TTM) | 460.89 | — |
| Forward P/E | 24.76 | 57.18 |
| EPS (TTM) | $0.18 | $-3.63 |
| Dividend yield | 2.19% | 0.00% |
| Annual dividend | $1.82 | $0.00 |
| 52-week high | $93.50 | $170.87 |
| 52-week low | $58.19 | $32.21 |
| Distance from 52-week high | -11.27% | -59.89% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +16.92% | +36.44% |
| Average volume | 204.60K | 728.47K |
| Shares outstanding | 14.92M | 29.82M |
| Employees | 4,653 | 1,300 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- USPH has outperformed WGS by 35.7 percentage points over the past year.
- U.S. Physical Therapy offers a meaningfully higher dividend yield (2.19% vs 0.00%).
About U.S. Physical Therapy
USPH stock →U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics.
Health Care · Medical/Nursing Services · 4,653 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
USPH vs WGS FAQ
Which is bigger, U.S. Physical Therapy or GeneDx?
GeneDx (WGS) is larger, with a market capitalization of $2.04B compared with $1.24B for U.S. Physical Therapy (USPH).
Which stock has performed better over the past year, USPH or WGS?
USPH returned -7.59% over the past 12 months, compared with -43.25% for WGS (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, U.S. Physical Therapy or GeneDx?
U.S. Physical Therapy pays a dividend yielding 2.19%, while GeneDx does not currently pay a regular dividend.
Are U.S. Physical Therapy and GeneDx in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.